Surgery Partners, Inc. - Common Stock (SGRY)

23.21
+0.00 (0.02%)
NASDAQ · Last Trade: Oct 30th, 3:18 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger
BFA Law is investigating the $23.50 per share merger, announced on October 26, 2026, in which Bon Secours Mercy Health, Inc. is set to acquire Surgery Partners, while Surgery Partners' largest stockholder, Bain Capital, is rolling over its equity into the post-merger entity; current stockholders are notified to contact the firm.
Via Newsfile · October 29, 2026
Halper Sadeh LLC is Investigating Whether SRGY, RRC, MFIC are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 
By Halper Sadeh LLC · Via GlobeNewswire · October 28, 2026
Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Surgery Partners, Inc. (NasdaqGS: SGRY) to HealthSpan Partners. Under the terms of the proposed transaction, shareholders of Surgery Partners will receive $23.50 in cash for each share of Surgery Partners that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
By Kahn Swick & Foti, LLC · Via Business Wire · October 27, 2026
SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware.
By Bleichmar Fonti & Auld LLP · Via Business Wire · October 27, 2026
Halper Sadeh LLC is Investigating Whether SRGY, CSR, SYNA are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 
By Halper Sadeh LLC · Via GlobeNewswire · October 27, 2026
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Surgery Partners, Inc. (“Surgery Partners” or “the Company”) (NASDAQ: SGRY) for potential breaches of fiduciary duty on the part of its directors and management.
By Schall, Brown & Schwartz LLP · Via Business Wire · October 26, 2026
Halper Sadeh LLC is Investigating Whether SRGY, RRC, UTZ are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 
By Halper Sadeh LLC · Via GlobeNewswire · October 26, 2026
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ)
BALA CYNWYD, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · October 26, 2026
SGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Surgery Partners, Inc. (NASDAQ: SGRY) to HealthSpan Partners for $23.50 in cash per share.
By Halper Sadeh LLC · Via Business Wire · October 26, 2026
HealthSpan Partners to Acquire Surgery Partners, Establishing a Leading Outpatient Surgical Care Platform
HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), and Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical facility owner and operator, today announced a definitive agreement under which HealthSpan Partners will acquire Surgery Partners in an all-cash transaction valued at an enterprise value of approximately $5.7 billion.
By HealthSpan Partners · Via Business Wire · October 26, 2026
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations.
Via MarketBeat · September 25, 2024
Surgery Partners feeling no pinch from macroeconomic weakness
Surgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states.
Via MarketBeat · January 16, 2024
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company’s board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board’s compensation committee.
By Teladoc Health, Inc. · Via GlobeNewswire · September 20, 2023
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.
Via MarketBeat · June 16, 2023